Fact CheckerSign in

NCT07712198Completed

Al Prediction of Sarcopenia Risk in Neurocritical ICU Patients

Artificial Intelligence-Based Prediction of Sarcopenia Risk in Intensive Care Unit Patients With Intracranial Pathology

Source: ClinicalTrials.gov · Last updated 24 Sept 2026

Brief summary (registry, in English)

This prospective observational study aims to evaluate sarcopenia in intensive care patients with intracranial pathologies using ultrasound and to compare the predictive performance of different artificial intelligence models. Rectus femoris muscle thickness will be measured by ultrasound on ICU admission (Day 0) and Day 7. Prealbumin levels will be assessed on Days 0, 3, and 7, and the modified Nutrition Risk in Critically Ill (mNUTRIC) score will be calculated on the first day of ICU admission. Clinical, laboratory, and ultrasonographic data will be integrated into different artificial intelligence models to predict sarcopenia status on Day 7. The study aims to determine the effectiveness of artificial intelligence in the early identification of sarcopenia and to support future clinical decision-making in intensive care practice.

Status (registry)
Completed
Study type
Observational
Enrollment
72 (actual)
First submitted
14 Jul 2026
Start date
1 Jan 2026
Primary completion date
30 Jun 2026
Lead sponsor
Trabzon Kanuni Education and Research Hospital
Diseases
Stroke
NCT number
NCT07712198

What you commit to

  • Study type: Observational
  • Participants enrolled: 72
  • From 1 Jan 2026 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to achieve nutritional targets according to ESPEN guidelines
  • History of neuromuscular disease
  • History of trauma affecting the thigh region

Age

  • Age \<18 years or \>65 years

Other

  • Palliative care or home care patients
  • Morbid obesity (BMI ≥40 kg/m²)
  • Lower extremity amputation
  • Pregnancy

Who the study is looking for

  • Age between 18 and 65 years
  • Admission to the intensive care unit due to intracranial pathology (intracerebral hemorrhage, epidural hemorrhage, subdural hemorrhage, subarachnoid hemorrhage, intracranial tumors, or ischemic stroke)
  • Informed consent obtained from the patient or legally authorized representative

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Trabzon University Faculty of Medicine, Kanuni Training and Research Hospital, Trabzon, 61080
Coordinator of this site? Confirm its status
TrabzonTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.